Teva to Buy CoGenesys for $400 Million
269527
Teva Pharmaceuticals of Israel, the largest generic-drug maker in the world, announced yesterday that it was acquiring the Rockville biotechnology company CoGenesys for $400 million.
331404
Ingram Micro Inc., the world&#39;s largest distributor of computer products, said Monday that is agreed to purchase Australian technology distributor Tech Pacific for about $493 million in cash, including assumed debt.
232138
MGI Pharma Inc. MOGN.O will spend up  to $85 million for a stake in SuperGen Inc. SUPG.O and global  rights to develop and sell SuperGen's experimental drug for an  often-fatal cancer of the bone marrow, the companies said on  Wednesday.
358538
Medical products company Abbott Laboratories said Monday it agreed to buy nutrition products company EAS Inc. in a cash-for-stock deal worth about $320 million.
688938
Gilead Sciences Inc. , the  world's third-biggest biotechnology company, said on Monday it  has agreed to acquire Myogen Inc.  for $2.5 billion in  a surprise transaction that gives Gilead access to Myogen's  experimental hypertension drugs.
507775
By Tricia Bishop, The Baltimore Sun  Dec. 14--One of MedImmune Inc.'s major shareholders is urging the state's flagship biotech to put itself up for sale, suggesting management hasn't made the most from its assets, which include four products on the market and about 40 in the pipeline.
738544
The cancer diagnostic equipment maker is expected to announce that it will acquire Spring Bioscience, a developer of antibodies, for $28.9 million in cash.
218831
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise $13.3 billion deal to buy   Europe's biggest biotech firm Serono SEO.VX on Thursday,   creating a new force in European pharmaceuticals.
482912
Qiagen NV , a Dutch maker of genetic testing equipment, said on Sunday it will acquire Digene Corp. ., which develops screening tests for diseases affecting women, for $1.6 billion in stock and cash.
466090
Teva Pharmaceutical Industries, which makes generic drugs, has won American approval to sell the first copies of GlaxoSmithKlineÂs Zofran for nausea related to chemotherapy and surgical procedures. Shipment will begin immediately, Teva said in a statement. The brand-name versions of the injections had sales of $695 million in the 12 months that ended in September, Teva said, citing figures from IMS Health.
133690
Business performance software vendor CognosÂ has agreed to buy Applix, a developer of performance analysis software, and plans to integrate the companies' products by early next year.
187272
KFAR SABA, Israel  - Teva Pharmaceutical  Industries Ltd., the world's largest generic drugmaker,  reported a 32 percent rise in fourth-quarter profit on Tuesday  and predicted sharply higher sales and profits in 2005.
205903
NEW YORK, December 7  - DaVita Inc (DVA.NYS) has agreed to acquire Gambroâs dialysis clinics in the US for $3.1 billion in cash, a Bloomberg article said today.
170831
GlaxoSmithKline Plc  has bought  global rights to Danish biotech company Genmab's  most  promising new drug, a treatment for leukemia, in a record deal  worth up to $2.1 billion, the two firms said on Tuesday.
737130
Platinum Equity will acquire Covad Communications for about $304 million, making the communications services company the latest technology company to sell to a private equity firm.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.
326538
Agriculture products company Monsanto Co.  on Monday said it will buy vegetable and fruit seed company Seminis Inc. for about &#36;1 billion in a move to capitalize on the trend toward healthier diets and enhance its portfolio of seed operations.